Posted by Michael Wonder on 10 Dec 2020
Proposal to widen access to febuxostat for prevention of tumour lysis syndrome
10 December 2020 - PHARMAC is seeking feedback on a proposal to widen access to febuxostat tablets.
PHARMAC is seeking feedback on a proposal to widen access to febuxostat tablets from 1 February 2021 to include some patients at risk of tumour lysis syndrome.
